Actualización en el manejo y el tratamiento del carcinoma epidermoide cutáneo avanzado

• Elisa Ríos-Viñuela ^[1] ; Onofre Sanmartín ^[1]
  1. [1] Instituto Valenciano de Oncologia

     Instituto Valenciano de Oncologia

     Valencia, España

     
• Localización: Piel: Formación continua en dermatología, ISSN 0213-9251, Vol. 37, Nº. 9 (Noviembre), 2022, págs. 529-533
• Idioma: español
• DOI: 10.1016/j.piel.2021.11.002
• Títulos paralelos:
  • Update on the management and treatment of advanced cutaneous squamous cell carcinoma
• Enlaces
  • Texto Completo Ejemplar
• Referencias bibliográficas
  • Cañueto J, Tejera-Vaquerizo A, Redondo P, Botella-Estrada R, Puig S, Sanmartin O. A review of terms used to define cutaneous squamous cell...
  • Alam M, Armstrong A, Baum C, et al. Guidelines of care for the management of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2018;78(3):560–578....
  • Gellrich FF, Hüning S, Beissert S, et al. Medical treatment of advanced cutaneous squamous-cell carcinoma. J Eur Acad Dermatology Venereol....
  • Stratigos AJ, Garbe C, Dessinioti C, et al. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: part 2....
  • Salzmann M, Leiter U, Loquai C, et al. Programmed cell death protein 1 inhibitors in advanced cutaneous squamous cell carcinoma: real-world...
  • Migden MR, Rischin D, Schmults CD, et al. PD-1 Blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma. N Engl J Med. 2018:341–351....
  • Eigentler TK, Leiter U, Häfner H-M, Garbe C, Röcken M, Breuninger H. Survival of patients with cutaneous squamous cell carcinoma: results...
  • Puebla-Tornero L, Corchete-Sánchez LA, Conde-Ferreirós A, et al. Performance of Salamanca refinement of the T3-AJCC8 versus the Brigham and...
  • Ruiz ES, Karia PS, Besaw R, Schmults CD. Performance of the American Joint Committee on cancer staging manual, 8th edition vs the Brigham...
  • Cañueto J, Burguillo J, Moyano-Bueno D, et al. Comparing the eighth and the seventh editions of the American Joint Committee on cancer staging...
  • Breuninger H, Eigentler T, Häfner HM, Leiter U. Local surgical treatment of cutaneous squamous cell carcinoma: deficits and controversies...
  • Leiter U, Heppt MV, Steeb T, et al. S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC)–short version, part 2:...
  • Hanna GJ, Ruiz ES, LeBoeuf NR, et al. Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint...
  • Cowey CL, Robert NJ, Espirito JL, et al. Clinical outcomes among unresectable, locally advanced, and metastatic cutaneous squamous cell carcinoma...
  • Maubec E, Petrow P, Scheer-Senyarich I, et al. Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable...
  • William WNJ, Feng L, Ferrarotto R, et al. Gefitinib for patients with incurable cutaneous squamous cell carcinoma: a singlearm phase II clinical...
  • Migden MR, Chandra S, Rabinowits G, et al. CASE (CemiplimAb-rwlc survivorship and epidemiology) study in advanced cutaneous squamous cell...
  • Markham A, Duggan S. Cemiplimab: first global approval. Drugs. 2018 Nov;78(17):1841–1846. https://doi.org/10.1007/ s40265-018-1012-5 PMID:...
  • Migden MR, Khushalani NI, Chang ALS, et al. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label,...
  • Rischin D, Migden MR, Lim AM, et al. Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis...